Expression levels of TEL, AML1, and the fusion products TEL-AML1 and AML1-TEL versus drug sensitivity and clinical outcome in t(12;21)-positive pediatric acute lymphoblastic leukemia

WAG (Wendy) Stams, Monique den Boer, Berna Beverloo, Jules Meijerink, ER van Wering, GE Janka-Schaub, Rob Pieters

Research output: Contribution to journalArticleAcademicpeer-review

17 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)2974-2980
Number of pages7
JournalClinical Cancer Research
Issue number8
Publication statusPublished - 2005

Cite this